logo
logo

Gencove Raises $10 Million To Meet The Global Demand For Accessible And Interpretable Whole Genome Sequencing At Scale

Oct 26, 2021•almost 4 years ago

Amount Raised

$10 Million

Description

Gencove, the leading low-pass genome sequencing platform company, today announced the successful close of a $10 million Series A investment bringing the company's total financing to $16.2 million. The round was led by Lewis & Clark AgriFood with participation from new and existing investors including Spero Ventures, Techammer, Third Kind Venture Capital, and Version One Ventures. Funding will be used for further product development, commercial growth and to build out key business functions.

Company Information

Company

Gencove

About

Gencove is democratizing genome sequencing by making genomic information more accessible and interpretable through the development of molecular and computational tools. Gencove's low-pass sequencing platform is setting a new standard for high-throughput, cost-effective genomics research across species. The company operates a laboratory in New York and offers both low-pass sequencing and analytics software as a service. Together with academic, agriculture, biotechnology, and pharmaceutical companies, Gencove is dedicated to solving the world's most pressing challenges. More information is available at www.gencove.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech